Provided by Tiger Trade Technology Pte. Ltd.

Scienture Holdings, Inc.

3.24
-0.6700-17.14%
Post-market: 3.350.1100+3.40%18:55 EDT
Volume:466.18K
Turnover:1.78M
Market Cap:5.32M
PE:-0.06
High:3.93
Open:3.93
Low:3.24
Close:3.91
52wk High:65.00
52wk Low:3.23
Shares:1.64M
Float Shares:1.28M
Volume Ratio:4.98
T/O Rate:36.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-50.7500
EPS(LYR):-67.6214
ROE:-53.47%
ROA:-8.93%
PB:0.08
PE(LYR):-0.05

Loading ...

Scienture Holdings, Inc Q2 Operating Expenses USD 3 Million

THOMSON REUTERS
·
Aug 14

Scienture Reports Q2 2026 Results with Approximately 510% Sequential Revenue Growth from Q1 2026 and Significant Improvement in Operating Performance

THOMSON REUTERS
·
Aug 14

Scienture Holdings Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Scienture Net Loss Narrows to $2.82 Million in Q2 FY26; Revenue Turns to $343,639

Reuters
·
Aug 14

Scienture Announces Commercial Launch and Fulfillment of Initial Purchase Orders of Rezenopy™, the Highest Dose FDA-Approved Naloxone Nasal Spray

THOMSON REUTERS
·
Aug 12

Scienture Holdings Inc Expected to Post a Loss of 23 Cents a Share - Earnings Preview

Reuters
·
Aug 07

When Will Scienture Holdings, Inc. (NASDAQ:SCNX) Become Profitable?

Simply Wall St.
·
Jul 27

Analysts Are Bullish on Top Healthcare Stocks: Scienture Holdings (SCNX), Royalty Pharma (RPRX)

TIPRANKS
·
Jul 10

Scienture Holdings Stock Jumps Over 20% Pre-Market: Here's Why

Benzinga
·
Jul 10

Scienture to begin shipments of Rezonopy to wholesalers

TIPRANKS
·
Jul 09

Scienture Holdings - to Begin July Shipments of Rezenopy Nasal Spray 10 Mg to U.S. Wholesalers

THOMSON REUTERS
·
Jul 09

SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY™ (naloxone hydrochloride) to Wholesalers

GlobeNewswire
·
Jul 09

Scienture announces progress in commercialization of Arbli

TIPRANKS
·
Jun 18

Scienture says large national health plan adds REZENOPY naloxone spray to formulary

Reuters
·
Jun 09

SCIENTURE Secures Formulary Coverage for REZENOPY™ with a Large National Health Plan and Expands Commercial Team

GlobeNewswire
·
Jun 09

Scienture wins US patent for REZENOPY naloxone nasal spray, protection through 2041

Reuters
·
Jun 02

Scienture Receives U.S. Patent Covering Rezenopy™ (Naloxone Hcl) Nasal Spray 10 Mg, Strengthening Intellectual Property Protection Through 2041

THOMSON REUTERS
·
Jun 02

SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041

GlobeNewswire
·
Jun 02

BRIEF-Scienture - Eric Sherb Resigns As CFO Effective May 26, 2026

Reuters
·
May 30

Scienture - Appoints Narasimhan Mani as Interim CFO Effective May 26, 2026 - SEC Filing

THOMSON REUTERS
·
May 30